Ubiquitin-mediated regulation of apoptosis

Trends in Cell Biology

Volumn 19, Issue 3, 2009, Pages 130-140

  Broemer, Meike ^a   Meier, Pascal ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EFFECTOR CASPASE; LIGASE; UBIQUITIN;

APOPTOSIS; CATALYSIS; CONFORMATION; CONJUGATION; MITOCHONDRION; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW;

ANIMALS; APOPTOSIS; HUMANS; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES;

EID: 61449134122     PISSN: 09628924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcb.2009.01.004     Document Type: Review

References (105)

1. Baehrecke E.H. How death shapes life during development. Nat. Rev. Mol. Cell Biol. 3 (2002) 779-787
2. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science 267 (1995) 1456-1462
3. Shi Y. Mechanisms of caspase activation and inhibition during apoptosis. Mol. Cell 9 (2002) 459-470
4. Meier P., and Vousden K.H. Lucifer's labyrinth-ten years of path finding in cell death. Mol. Cell 28 (2007) 746-754
5. Green D.R., and Kroemer G. The pathophysiology of mitochondrial cell death. Science 305 (2004) 626-629
6. Li P., et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91 (1997) 479-489
7. Zou H., et al. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90 (1997) 405
8. Haglund K., and Dikic I. Ubiquitylation and cell signaling. EMBO J. 24 (2005) 3353-3359
9. Jang M., et al. Caspase-7 mediated cleavage of proteasome subunits during apoptosis. Biochem. Biophys. Res. Commun. 363 (2007) 388-394
10. Sun X.M., et al. Caspase activation inhibits proteasome function during apoptosis. Mol. Cell 14 (2004) 81-93
11. Brooks C.L., and Gu W. p53 ubiquitination: Mdm2 and beyond. Mol. Cell 21 (2006) 307-315
12. Vaux D.L., and Silke J. IAPs, RINGs and ubiquitylation. Nat. Rev. Mol. Cell Biol. 6 (2005) 287-297
13. Shi Y. A conserved tetrapeptide motif: potentiating apoptosis through IAP-binding. Cell Death Differ. 9 (2002) 93-95
14. Silke J., and Vaux D.L. Two kinds of BIR-containing protein - inhibitors of apoptosis, or required for mitosis. J. Cell Sci. 114 (2001) 1821-1827
15. Srinivasula S.M., and Ashwell J.D. IAPs: what's in a name?. Mol. Cell 30 (2008) 123-135
16. Eckelman B.P., et al. Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family. EMBO Rep. 7 (2006) 988-994
17. Silke J., et al. Direct inhibition of caspase 3 is dispensable for the anti-apoptotic activity of XIAP. EMBO J. 20 (2001) 3114-3123
18. Chai J., et al. Structural basis of caspase-7 inhibition by XIAP. Cell 104 (2001) 769-780
19. Huang Y., et al. Structural basis of caspase inhibition by XIAP: differential roles of the linker versus the BIR domain. Cell 104 (2001) 781-790
20. Riedl S.J., et al. Structural basis for the inhibition of caspase-3 by XIAP. Cell 104 (2001) 791-800
21. Suzuki Y., et al. X-linked inhibitor of apoptosis protein (XIAP) inhibits caspase-3 and - 7 in distinct modes. J. Biol. Chem. 276 (2001) 27058-27063
22. Shiozaki E.N., et al. Mechanism of XIAP-mediated inhibition of caspase-9. Mol. Cell 11 (2003) 519
23. Schile A.J., et al. Regulation of apoptosis by XIAP ubiquitin-ligase activity. Genes Dev. 22 (2008) 2256-2266
24. Suzuki Y., et al. Ubiquitin-protein ligase activity of X-linked inhibitor of apoptosis protein promotes proteasomal degradation of caspase-3 and enhances its anti-apoptotic effect in Fas-induced cell death. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 8662-8667
25. Morizane Y., et al. X-linked inhibitor of apoptosis functions as ubiquitin ligase toward mature caspase-9 and cytosolic Smac/DIABLO. J. Biochem. 137 (2005) 125-132
26. Bartke T., et al. Dual role of BRUCE as an antiapoptotic IAP and a chimeric E2/E3 ubiquitin ligase. Mol. Cell 14 (2004) 801-811
27. Hao Y., et al. Apollon ubiquitinates SMAC and caspase-9, and has an essential cytoprotection function. Nat. Cell Biol. 6 (2004) 849-860
28. Arama E., et al. Caspase activity and a specific cytochrome C are required for sperm differentiation in Drosophila. Dev. Cell 4 (2003) 687-697
29. Vernooy S.Y., et al. Drosophila Bruce can potently suppress Rpr- and Grim-dependent but not Hid-dependent cell death. Curr. Biol. 12 (2002) 1164-1168
30. Crook N.E., et al. An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif. J. Virol. 67 (1993) 2168-2174
31. Lisi S., et al. Diverse domains of THREAD/DIAP1 are required to inhibit apoptosis induced by REAPER and HID in Drosophila. Genetics 154 (2000) 669-678
32. Wang S.L., et al. The Drosophila caspase inhibitor DIAP1 is essential for cell survival and is negatively regulated by HID. Cell 98 (1999) 453-463
33. Wilson R., et al. The DIAP1 RING finger mediates ubiquitination of Dronc and is indispensable for regulating apoptosis. Nat. Cell Biol. 4 (2002) 445-450
34. Chai J., et al. Molecular mechanism of Reaper-Grim-Hid-mediated suppression of DIAP1-dependent Dronc ubiquitination. Nat. Struct. Biol. 10 (2003) 892-898
35. Herman-Bachinsky Y., et al. Regulation of the Drosophila ubiquitin ligase DIAP1 is mediated via several distinct ubiquitin system pathways. Cell Death Differ. 14 (2007) 861-871
36. Tenev T., et al. IAPs are functionally non-equivalent and regulate effector caspases through distinct mechanisms. Nat. Cell Biol. 7 (2005) 70-77
37. Ditzel M., et al. Degradation of DIAP1 by the N-end rule pathway is essential for regulating apoptosis. Nat. Cell Biol. 5 (2003) 467-473
38. Ryoo H.D., et al. Apoptotic cells can induce compensatory cell proliferation through the JNK and the Wingless signaling pathways. Dev. Cell 7 (2004) 491-501
39. Muro I., et al. The Drosophila DIAP1 protein is required to prevent accumulation of a continuously generated, processed form of the apical caspase DRONC. J. Biol. Chem. 277 (2002) 49644-49650
40. Shapiro P.J., et al. Regulation of the Drosophila apoptosome through feedback inhibition. Nat. Cell Biol. 10 (2008) 1440-1446
41. Huang H., et al. The inhibitor of apoptosis, cIAP2, functions as a ubiquitin-protein ligase and promotes in vitro monoubiquitination of caspases 3 and 7. J. Biol. Chem. 275 (2000) 26661-26664
42. Harlin H., et al. Characterization of XIAP-deficient mice. Mol. Cell. Biol. 21 (2001) 3604-3608
43. Ditzel M., et al. Inactivation of effector caspases through nondegradative polyubiquitylation. Mol. Cell 32 (2008) 540-553
44. Tasaki T., and Kwon Y.T. The mammalian N-end rule pathway: new insights into its components and physiological roles. Trends Biochem. Sci. 32 (2007) 520-528
45. Ribeiro P.S., et al. DIAP2 functions as a mechanism-based regulator of drICE that contributes to the caspase activity threshold in living cells. J. Cell Biol. 179 (2007) 1467-1480
46. Zimmermann K.C., et al. The role of ARK in stress-induced apoptosis in Drosophila cells. J. Cell Biol. 156 (2002) 1077-1087
47. Gesellchen V., et al. An RNA interference screen identifies Inhibitor of apoptosis protein 2 as a regulator of innate immune signalling in Drosophila. EMBO Rep. 6 (2005) 979-984
48. Huh J.R., et al. The Drosophila inhibitor of apoptosis (IAP) DIAP2 is dispensable for cell survival, required for the innate immune response to gram-negative bacterial infection, and can be negatively regulated by the reaper/hid/grim family of IAP-binding apoptosis inducers. J. Biol. Chem. 282 (2007) 2056-2068
49. Kleino A., et al. Inhibitor of apoptosis 2 and TAK1-binding protein are components of the Drosophila Imd pathway. EMBO J. 24 (2005) 3423-3434
50. Leulier F., et al. The Drosophila inhibitor of apoptosis protein DIAP2 functions in innate immunity and is essential to resist gram-negative bacterial infection. Mol. Cell. Biol. 26 (2006) 7821-7831
51. Micheau O., and Tschopp J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114 (2003) 181
52. Schneider-Brachert W., et al. Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles. Immunity 21 (2004) 415-428
53. Ea C.K., et al. Activation of IKK by TNFα requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol. Cell 22 (2006) 245-257
54. Yu J.W., and Shi Y. FLIP and the death effector domain family. Oncogene 27 (2008) 6216-6227
55. Santoro M.M., et al. Birc2 (cIap1) regulates endothelial cell integrity and blood vessel homeostasis. Nat. Genet. 39 (2007) 1397-1402
56. Vince J.E., et al. IAP antagonists target cIAP1 to induce TNFα-dependent apoptosis. Cell 131 (2007) 682-693
57. Gaither A., et al. A Smac mimetic rescue screen reveals roles for inhibitor of apoptosis proteins in tumor necrosis factor-α signaling. Cancer Res. 67 (2007) 11493-11498
58. Petersen S.L., et al. Autocrine TNFα signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis. Cancer Cell 12 (2007) 445-456
59. Varfolomeev E., et al. IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFα-dependent apoptosis. Cell 131 (2007) 669-681
60. Bertrand M.J., et al. cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. Mol. Cell 30 (2008) 689-700
61. O'Donnell M.A., et al. Ubiquitination of RIP1 regulates an NF-κB-independent cell-death switch in TNF signaling. Curr. Biol. 17 (2007) 418-424
62. Vallabhapurapu S., et al. Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-κB signaling. Nat. Immunol. 9 (2008) 1364-1370
63. Zarnegar B., et al. Control of canonical NF-κB activation through the NIK-IKK complex pathway. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 3503-3508
64. Varfolomeev E., et al. c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor α (TNFα)-induced NF-κB activation. J. Biol. Chem. 283 (2008) 24295-24299
65. Yang Q.H., and Du C. Smac/DIABLO selectively reduces the levels of c-IAP1 and c-IAP2 but not that of XIAP and livin in HeLa cells. J. Biol. Chem. 279 (2004) 16963-16970
66. Gyrd-Hansen M., et al. IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-κB as well as cell survival and oncogenesis. Nat. Cell Biol. 10 (2008) 1309-1317
67. Baens M., et al. The product of the t(11;18), an API2-MLT fusion, marks nearly half of gastric MALT type lymphomas without large cell proliferation. Am. J. Pathol. 156 (2000) 1433-1439
68. Akiyama T., et al. Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim. EMBO J. 22 (2003) 6653-6664
69. Ley R., et al. Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein. Bim. J. Biol. Chem. 278 (2003) 18811-18816
70. Wiggins C.M., et al. c-Cbl is not required for ERK1/2-dependent degradation of BimEL. Cell. Signal. 19 (2007) 2605-2611
71. Tait S.W., et al. Apoptosis induction by Bid requires unconventional ubiquitination and degradation of its N-terminal fragment. J. Cell Biol. 179 (2007) 1453-1466
72. Cadwell K., and Coscoy L. Ubiquitination on nonlysine residues by a viral E3 ubiquitin ligase. Science 309 (2005) 127-130
73. Wang X., et al. Ubiquitination of serine, threonine, or lysine residues on the cytoplasmic tail can induce ERAD of MHC-I by viral E3 ligase mK3. J. Cell Biol. 177 (2007) 613-624
74. Le Gouill S., et al. Mcl-1 regulation and its role in multiple myeloma. Cell Cycle 3 (2004) 1259-1262
75. Zhong Q., et al. Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis. Cell 121 (2005) 1085-1095
76. Chen D., et al. ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor. Cell 121 (2005) 1071-1083
77. Nijman S.M., et al. A genomic and functional inventory of deubiquitinating enzymes. Cell 123 (2005) 773-786
78. Sun S.C. Deubiquitylation and regulation of the immune response. Nat. Rev. Immunol. 8 (2008) 501-511
79. Trompouki E., et al. CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members. Nature 424 (2003) 793-796
80. Wertz I.E., et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling. Nature 430 (2004) 694-699
81. Enesa K., et al. NF-κB suppression by the deubiquitinating enzyme Cezanne: a novel negative feedback loop in pro-inflammatory signaling. J. Biol. Chem. 283 (2008) 7036-7045
82. Shembade N., et al. The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20. Nat. Immunol. 9 (2008) 254-262
83. Chang L., et al. The E3 ubiquitin ligase itch couples JNK activation to TNFα-induced cell death by inducing c-FLIP(L) turnover. Cell 124 (2006) 601-613
84. Ryoo H.D., et al. Regulation of Drosophila IAP1 degradation and apoptosis by reaper and ubcD1. Nat. Cell Biol. 4 (2002) 432-438
85. Wing J.P., et al. Drosophila Morgue is an F box/ubiquitin conjugase domain protein important for grim-reaper mediated apoptosis. Nat. Cell Biol. 4 (2002) 451-456
86. Hunter A.M., et al. The inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis 12 (2007) 1543-1568
87. Hays R., et al. Morgue mediates apoptosis in the Drosophila melanogaster retina by promoting degradation of DIAP1. Nat. Cell Biol. 4 (2002) 425-431
88. Kuranaga E., et al. Drosophila IKK-related kinase regulates nonapoptotic function of caspases via degradation of IAPs. Cell 126 (2006) 583-596
89. Gallagher E., et al. Activation of the E3 ubiquitin ligase Itch through a phosphorylation-induced conformational change. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 1717-1722
90. Qiu X.B., et al. Nrdp1-mediated degradation of the gigantic IAP, BRUCE, is a novel pathway for triggering apoptosis. EMBO J. 23 (2004) 800-810
91. Sekine K., et al. HtrA2 cleaves Apollon and induces cell death by IAP-binding motif in Apollon-deficient cells. Biochem. Biophys. Res. Commun. 330 (2005) 279-285
92. Tanimura S., et al. MDM2 interacts with MDMX through their RING finger domains. FEBS Lett. 447 (1999) 5-9
93. Mace P.D., et al. Structures of the cIAP2 RING domain reveal conformational changes associated with Ubiquitin-conjugating Enzyme (E2) recruitment. J. Biol. Chem. 283 (2008) 31633-31640
94. Poyurovsky M.V., et al. The Mdm2 RING domain C-terminus is required for supramolecular assembly and ubiquitin ligase activity. EMBO J. 26 (2007) 90-101
95. Silke J., et al. Determination of cell survival by RING-mediated regulation of inhibitor of apoptosis (IAP) protein abundance. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 16182-16187
96. Conze D.B., et al. Posttranscriptional downregulation of c-IAP2 by the ubiquitin protein ligase c-IAP1 in vivo. Mol. Cell. Biol. 25 (2005) 3348-3356
97. Lee T.V., et al. The E1 ubiquitin-activating enzyme Uba1 in Drosophila controls apoptosis autonomously and tissue growth non-autonomously. Development 135 (2008) 43-52
98. Kerscher O., et al. Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu. Rev. Cell Dev. Biol. 22 (2006) 159-180
99. Meier P., et al. The Drosophila caspase DRONC is regulated by DIAP1. EMBO J. 19 (2000) 598-611
100. Hershko A., et al. Basic Medical Research Award. The ubiquitin system. Nat. Med. 6 (2000) 1073-1081
101. Hoeller D., et al. Ubiquitin and ubiquitin-like proteins in cancer pathogenesis. Nat. Rev. Cancer 6 (2006) 776-788
102. Di Fiore P.P., et al. When ubiquitin meets ubiquitin receptors: a signalling connection. Nat. Rev. Mol. Cell Biol. 4 (2003) 491-497
103. Husnjak K., et al. Proteasome subunit Rpn13 is a novel ubiquitin receptor. Nature 453 (2008) 481-488
104. Wertz I.E., and Dixit V.M. Ubiquitin-mediated regulation of TNFR1 signaling. Cytokine Growth Factor Rev. 19 (2008) 313-324
105. Karin M., and Lin A. NF-κB at the crossroads of life and death. Nat. Immunol. 3 (2002) 221-227